Viatris
News/ News/ Sales and Marketing
Update: FDA clears first generic of AZ’s blockbuster Symbicort
Phil Taylor
asthma, AstraZeneca, Chronic Obstructive Pulmonary Disease, regulatory approval, Symbicort, Viatris
0 Comment
X
Update: FDA clears first generic of AZ’s blockbuster Symbicort
https://pharmaphorum.com/news/fda-clears-first-generic-of-azs-blockbuster-symbicort/
X
Biocon buys Viatris biosimilars for $3.3bn, eyes IPO
https://pharmaphorum.com/news/biocon-buys-viatris-biosimilars-for-3-3bn-eyes-ipo/
AstraZeneca breathes sigh of relief as court blocks US Symbicort generic
Richard Staines
asthma, AstraZeneca, COPD, litigation, patent, respiratory, Symbicort, Viatris
0 Comment
X
AstraZeneca breathes sigh of relief as court blocks US Symbicort generic
https://pharmaphorum.com/news/astrazeneca-breathes-sigh-of-relief-as-court-blocks-us-symbicort-generic/
News/ News/ Sales and Marketing
FTC clears Mylan merger with Pfizer’s Upjohn – with conditions
Phil Taylor
competition, generic, M&A, Mylan, Pfizer, regulatory, Viatris
0 Comment
X
FTC clears Mylan merger with Pfizer’s Upjohn – with conditions
https://pharmaphorum.com/news/ftc-clears-mylan-merger-with-pfizers-upjohn-with-conditions/